Capital Impact Advisors’s Twist Bioscience TWST Stock Holding History
Bought
Maintained
Sold
Other funds holding TWST
AIM
NAMA
Capital Impact Advisors's TWST Position: Q3 2024 in Review
Capital Impact Advisors sold out of Twist Bioscience (TWST) in Q3 2024, closing a stake of 20,380 shares — an estimated $1M sold.
Capital Impact Advisors first reported a position in TWST in Q3 2020 and held it in 15 quarters. The position peaked at $13.7M in Q4 2020. 245 funds tracked by Wall St. Rank hold TWST as of Q3 2024.
- Capital Impact Advisors reported no remaining Twist Bioscience position as of Q3 2024 after selling out during the quarter.
- Capital Impact Advisors sold 20,380 Twist Bioscience shares in Q3 2024, an estimated $1M.
- Capital Impact Advisors first reported a position in Twist Bioscience in Q3 2020 and held it in 15 quarters.
- Capital Impact Advisors's Twist Bioscience position peaked at $13.7M in Q4 2020.
- 245 funds tracked by Wall St. Rank held Twist Bioscience as of Q3 2024.
Based on Capital Impact Advisors's 13F filing for Q3 2024, filed 14 Nov 2024.